IL130500A - Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions - Google Patents

Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions

Info

Publication number
IL130500A
IL130500A IL13050097A IL13050097A IL130500A IL 130500 A IL130500 A IL 130500A IL 13050097 A IL13050097 A IL 13050097A IL 13050097 A IL13050097 A IL 13050097A IL 130500 A IL130500 A IL 130500A
Authority
IL
Israel
Prior art keywords
medicament
prevention
manufacture
comt inhibitors
diabetic vascular
Prior art date
Application number
IL13050097A
Other languages
English (en)
Other versions
IL130500A0 (en
Original Assignee
Orion Yhtymae Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orion Yhtymae Oyj filed Critical Orion Yhtymae Oyj
Publication of IL130500A0 publication Critical patent/IL130500A0/xx
Publication of IL130500A publication Critical patent/IL130500A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/12Ketones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL13050097A 1996-12-20 1997-12-19 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions IL130500A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9626472.6A GB9626472D0 (en) 1996-12-20 1996-12-20 New use of comt inhibitors
PCT/FI1997/000812 WO1998027973A1 (en) 1996-12-20 1997-12-19 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions

Publications (2)

Publication Number Publication Date
IL130500A0 IL130500A0 (en) 2000-06-01
IL130500A true IL130500A (en) 2003-02-12

Family

ID=10804746

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13050097A IL130500A (en) 1996-12-20 1997-12-19 Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions

Country Status (23)

Country Link
US (1) US6207706B1 (no)
EP (1) EP0964678B1 (no)
JP (1) JP2001507006A (no)
KR (1) KR20000057628A (no)
AT (1) ATE234613T1 (no)
AU (1) AU714086B2 (no)
BG (1) BG103491A (no)
CA (1) CA2275681A1 (no)
CZ (1) CZ291117B6 (no)
DE (1) DE69720064D1 (no)
EA (1) EA001673B1 (no)
EE (1) EE9700350A (no)
GB (1) GB9626472D0 (no)
HU (1) HUP0001097A3 (no)
IL (1) IL130500A (no)
NO (1) NO992985D0 (no)
NZ (1) NZ336043A (no)
PL (1) PL334093A1 (no)
SK (1) SK79999A3 (no)
TR (1) TR199901206T2 (no)
WO (1) WO1998027973A1 (no)
YU (1) YU28599A (no)
ZA (1) ZA9711468B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI20000635A0 (fi) 2000-03-17 2000-03-17 Orion Yhtymae Oyj COMT-inhibiittoreiden käyttö analgeettina
FI20001593A (fi) 2000-07-03 2002-01-04 Orion Yhtymo Oyj Comt-entsyymiõ inhiboivaa aktiivisuutta omaavia kumariinijohdannaisia
FI20002044A0 (fi) 2000-09-15 2000-09-15 Orion Yhtymae Oyj Comt-entsyymiä estäviä naftaleenijohdannaisia
MY148644A (en) * 2005-07-18 2013-05-15 Orion Corp New pharmaceutical compounds
TWI638802B (zh) 2012-05-24 2018-10-21 芬蘭商奧利安公司 兒茶酚o-甲基轉移酶活性抑制化合物
JP2021532133A (ja) 2018-07-25 2021-11-25 オリオン コーポレーション 4,5−ジヒドロキシ−2−(4−メチルベンジル)イソフタロニトリル溶媒和物およびその結晶形
WO2020094928A1 (en) 2018-11-09 2020-05-14 Orion Corporation Process for the preparation of 4,5-dihydroxy-2-(4-methylbenzyl)isophthalonitrile

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4672042A (en) 1981-12-21 1987-06-09 Orion Research Puerto Rico, Inc. Method of and apparatus for chromatographic analysis
DK175069B1 (da) 1986-03-11 2004-05-24 Hoffmann La Roche Pyrocatecholderivater
US5236952A (en) * 1986-03-11 1993-08-17 Hoffmann-La Roche Inc. Catechol derivatives
FI864875A0 (fi) 1986-11-28 1986-11-28 Orion Yhtymae Oy Nya farmakologiskt aktiva foereningar, dessa innehaollande kompositioner samt foerfarande och mellanprodukter foer anvaendning vid framstaellning av dessa.
YU213587A (en) 1986-11-28 1989-06-30 Orion Yhtymae Oy Process for obtaining new pharmacologic active cateholic derivatives
US5283352A (en) * 1986-11-28 1994-02-01 Orion-Yhtyma Oy Pharmacologically active compounds, methods for the preparation thereof and compositions containing the same
US5489614A (en) 1987-11-27 1996-02-06 Orion-Yhtyma Oy Catechol derivatives, their physiologically acceptable salts, esters and use
MTP1031B (en) * 1987-12-24 1990-10-04 Orion Yhtymae Oy New use of cathecol-o-methyl transferase (comt) inhibitors and their physiologically acceptable salts and esters
IL91382A (en) 1988-09-01 1995-06-29 Orion Yhtymae Oy Dicitons are converted into alkanyl or ethylmethylene, through their preparation and pharmaceutical preparations containing them
US5185370A (en) 1988-09-01 1993-02-09 Orion-Yhtyma Oy Substituted β-diketones and their use
GB8903130D0 (en) 1989-02-11 1989-03-30 Orion Yhtymae Oy Substituted pyridazinones
US5185332A (en) 1989-02-11 1993-02-09 Orion-Yhtyma Oy Thiadiazines and pharmaceutical compositions thereof as well as method of use
GB9510481D0 (en) 1995-05-24 1995-07-19 Orion Yhtymae Oy New catechol derivatives

Also Published As

Publication number Publication date
CA2275681A1 (en) 1998-07-02
ATE234613T1 (de) 2003-04-15
EP0964678B1 (en) 2003-03-19
PL334093A1 (en) 2000-01-31
NZ336043A (en) 2000-12-22
CZ223199A3 (cs) 1999-11-17
WO1998027973A1 (en) 1998-07-02
TR199901206T2 (xx) 1999-08-23
EA001673B1 (ru) 2001-06-25
SK79999A3 (en) 2000-05-16
EA199900579A1 (ru) 1999-12-29
HUP0001097A2 (hu) 2000-09-28
HUP0001097A3 (en) 2003-05-28
NO992985L (no) 1999-06-17
EP0964678A1 (en) 1999-12-22
NO992985D0 (no) 1999-06-17
EE9700350A (et) 1998-10-15
DE69720064D1 (de) 2003-04-24
IL130500A0 (en) 2000-06-01
GB9626472D0 (en) 1997-02-05
KR20000057628A (ko) 2000-09-25
YU28599A (sh) 2002-03-18
AU7871198A (en) 1998-07-17
CZ291117B6 (cs) 2002-12-11
JP2001507006A (ja) 2001-05-29
BG103491A (bg) 2000-04-28
US6207706B1 (en) 2001-03-27
AU714086B2 (en) 1999-12-16
ZA9711468B (en) 1998-08-29

Similar Documents

Publication Publication Date Title
MX9700538A (es) Uso de droloxifeno y sus sales farmaceuticamente aceptables en la preparacion de remedios para las enfermedades cardiovasculares.
NZ515567A (en) Method for treating chronic pain using MEK inhibitors
AU7321598A (en) Use of cholinesterase inhibitors to treat disorders of attention
HUP9904221A3 (en) Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia for producing pharmaceutical compositions
NZ503233A (en) Synergistic analgesic combination of opioid analgesic and COX-2 inhibitor
YU63699A (sh) Preparati za tretiranje i prevenciju arterijske tromboze i korišćenje inhibitora faktora xa samog ili u kombinaciji sa plateletnim antiagregacionim agensom
YU82602A (sh) Korišćenje il-18 inhibitora za lečenje i/ili prevenciju ateroskleroze
HK1068106A1 (en) Use of sarp-1 for the treatment and/or prevention of scleroderma
AU2001246600A1 (en) Use of comt inhibitors as analgesics
GB0020504D0 (en) Therapeutic method
IL130500A0 (en) Use of comt inhibitors for the manufacture of a medicament for the prevention of diabetic vascular dysfunctions
GB9521608D0 (en) Pharmaceutical composition
IL124236A (en) Pharmaceutical composition for treating or reversing diabetic cardiomyopathy comprising aldose reductase inhibitor
ZA923935B (en) New 2-amino-5-cyano-1,4-dihydropyridines,processes for their preparation and their use in medicaments
ZA969586B (en) The use of cholinesterase inhibitors in the treatment of xerostomia
SI1003554T1 (en) Proton pump inhibitor in therapeutic combination with antibacterial substances
AU5434899A (en) Cancer treatment
IL126158A0 (en) Method for treating substance abuse
WO2002005796A3 (en) Use of a spla2 inhibitor for the treatment of sepsis
HUP9903979A3 (en) Use of nitric oxidesynthase inhibitors to treat or prevent type ii diabetes
ZA983753B (en) Medicinal composition for treatment of burns, cuts and like wounds.
MY118982A (en) Method of reducing tissue damage associated with ischemia
PL328949A1 (en) Method of treatng excessive aggression
EP0810866A4 (en) USE IN THE TREATMENT OF CANCERS OF ORGANOMETALLIC COMPOUNDS OF ACID-SENSITIVE TRANSITION METALS
BG102974A (en) Ethene-containing solutions and their use in methods of treatment or prevention

Legal Events

Date Code Title Description
FF Patent granted
RH1 Patent not in force